Skip to main content
Top

Drugs

Issue 1/2020

Content (10 Articles)

Management of Opioid-Tolerant Patients with Acute Pain: Approaching the Challenges

Pamela E. Macintyre, Lindy J. Roberts, Christine A. Huxtable

Treating Persistent Pain After Breast Cancer Surgery

James S. Khan, Karim S. Ladha, Faraj Abdallah, Hance Clarke

Costimulation Blockade in Kidney Transplant Recipients

Marieke van der Zwan, Dennis A. Hesselink, Martijn W. F. van den Hoogen, Carla C. Baan

Comparative Safety Profile of the Fixed-Dose Combination Corticosteroid and Long-acting β2-Agonist Fluticasone Propionate/Formoterol Fumarate: A 36-Month Longitudinal Cohort Study in UK Primary Care

David B. Price, Victoria Carter, Jessica Martin, Elizabeth A. Gardener, Derek Skinner, Sen Yang, Matthias Hoffman, Jenna C. Willis, Andrew J. Cooper

Cenobamate: First Approval

Susan J. Keam

Crizanlizumab: First Approval

Hannah A. Blair

Luspatercept: First Approval

Anthony Markham

Zanubrutinib: First Approval

Yahiya Y. Syed

Keynote webinar | Spotlight on dry eye disease

  • Live
  • Webinar | 28-05-2026 | 13:00 (CEST)

DED is highly prevalent yet challenging to diagnose and treat. Join leading experts to explore the latest developments and gain practical guidance on effective management in busy clinical settings. Brought to you by Springer Medicine and Eye.

Watch it live: 28 May 2026, 13:00–14:00 (CEST)

Prof. Harminder Dua
Prof. Sajjad Ahmad
Prof. Anat Galor
Join the webinar
Webinar
Image Credits
Conceptual illustration of dry eye disease/© Science Photo Library / Getty Images